Clinical trial
RheOx European Post-Market Clinical Study
NCT04182841 is registered in ClinicalTrials.gov with Gala Therapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- RheOx European Post-Market Clinical Study
- Lead sponsor
- Gala Therapeutics, Inc.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 9, 2020
- Completion date
- December 15, 2025
- Enrollment
- 100 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
chronic bronchitis, copd